Sarasota, FL, United States of America

Russell H Samson

This inventor holds 1 USPTO granted patent. Top assignee: Daishowa Chemicals Inc.. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Russell H Samson. Retrieved from https://idiyas.com/inventor/russell-h-samson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Russell H Samson: Innovator in Pharmacological Agents

Introduction

Russell H Samson is a notable inventor based in Sarasota, FL (US). He has made significant contributions to the field of pharmacology, particularly with his innovative work on lignosulfonate-based agents. His research focuses on developing effective treatments that minimize side effects while providing therapeutic benefits.

Latest Patents

Russell H Samson holds a patent for a lignosulfonate-based pharmacologic agent with anti-coagulant properties. This invention is designed to inhibit deep venous thrombophlebitis without affecting blood coagulation. The lignosulfonate is derived from softwood spent sulfite liquor and is administered in low dosages ranging from about 0.05 to about 1.0 mg/milliliter of blood. The patent also discloses a method for making and administering this lignosulfonate.

Career Highlights

Throughout his career, Samson has been associated with Daishowa Chemicals Inc., where he has applied his expertise in pharmacology to develop innovative solutions. His work has garnered attention for its potential to improve patient outcomes in the treatment of thrombotic conditions.

Collaborations

One of his notable collaborators is John W Hollis, Jr., who has worked alongside Samson in advancing their research initiatives.

Conclusion

Russell H Samson's contributions to pharmacology, particularly through his patented lignosulfonate-based agent, highlight his commitment to innovation in medical treatments. His work continues to pave the way for advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…